Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.
Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check63 days agoChange DetectedThe page has removed an erratum related to the safety profile of upadacitinib in rheumatoid arthritis, which may affect the completeness of the information presented.SummaryDifference0.1%
- Check78 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check85 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed objectives and study design for a clinical trial on rheumatoid arthritis, while adding new information about the interventional model and a revision number.SummaryDifference14%
- Check173 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check185 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference0.1%
- Check207 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.